Advertisement

Topics

Galsky Discusses Ongoing Combination Immunotherapy Trials in Bladder Cancer

12:27 EDT 13 Jul 2018 | OncLive

Matthew Galsky, MD, discusses the IMvigor and CheckMate-901 studies 130, as well as the future for chemotherapy in bladder cancer.

Original Article: Galsky Discusses Ongoing Combination Immunotherapy Trials in Bladder Cancer

NEXT ARTICLE

More From BioPortfolio on "Galsky Discusses Ongoing Combination Immunotherapy Trials in Bladder Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...